Cargando…

Material characterization of GPX(®): A versatile in situ solidifying embolic platform technology

Endovascular embolization is a minimally invasive procedure during which blood flow to targeted tissues is selectively occluded. The list of clinical indications for embolization continues to expand. Liquid embolic agents are injectable compositions that transition into a solid or semi-solid form wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Stewart, Russell J., Sima, Monika, Karz, Jessica, Jones, Joshua P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885798/
https://www.ncbi.nlm.nih.gov/pubmed/36726745
http://dx.doi.org/10.3389/fbioe.2023.1095148
_version_ 1784880004663869440
author Stewart, Russell J.
Sima, Monika
Karz, Jessica
Jones, Joshua P.
author_facet Stewart, Russell J.
Sima, Monika
Karz, Jessica
Jones, Joshua P.
author_sort Stewart, Russell J.
collection PubMed
description Endovascular embolization is a minimally invasive procedure during which blood flow to targeted tissues is selectively occluded. The list of clinical indications for embolization continues to expand. Liquid embolic agents are injectable compositions that transition into a solid or semi-solid form when introduced into blood vessels. The mechanism that triggers the liquid-to-solid transition is a key distinguishing feature of liquid embolic agents. GPX is a waterborne liquid embolic agent comprising oppositely charged polyelectrolytes: polyguanidinum and inorganic polyphoshate. In situ solidification is driven by electrostatic condensation of the polyelectrolytes, triggered by ionic strength differentials. We report in vitro characterization of the material properties of GPX, it is in vivo effectiveness in acute animal studies, and its potential for chemoembolization. The viscosity of GPX can be varied over a wide range by adjusting the polyguanidinium MW and/or concentration. Formulation of GPX with either tantalum microparticles (30 wt%) or iodinated radiocontrast agents (300 mgI ml(−1)) did not significantly change the flow behavior of GPX; the viscosity was independent of shear rate and remained within a clinically practical range (80–160 cP). Formulation of GPX with doxorubicin substantially increased viscosity at low shear rates and resulted in a power law dependence on shear rate. High contrast and effective vascular occlusion were demonstrated in both swine kidneys and rete mirabile. Contrast from iodinated compounds was temporary, dissipating within hours. The doxorubicin in vitro release profile was linear over 90 days. The results demonstrate that GPX is a versatile liquid embolic platform that can be formulated with a wide range of viscosities injectable at clinically practical flow rates, with either transient or permanent contrast, and that can provide prolonged zero-order delivery of doxorubicin to embolized tissues.
format Online
Article
Text
id pubmed-9885798
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98857982023-01-31 Material characterization of GPX(®): A versatile in situ solidifying embolic platform technology Stewart, Russell J. Sima, Monika Karz, Jessica Jones, Joshua P. Front Bioeng Biotechnol Bioengineering and Biotechnology Endovascular embolization is a minimally invasive procedure during which blood flow to targeted tissues is selectively occluded. The list of clinical indications for embolization continues to expand. Liquid embolic agents are injectable compositions that transition into a solid or semi-solid form when introduced into blood vessels. The mechanism that triggers the liquid-to-solid transition is a key distinguishing feature of liquid embolic agents. GPX is a waterborne liquid embolic agent comprising oppositely charged polyelectrolytes: polyguanidinum and inorganic polyphoshate. In situ solidification is driven by electrostatic condensation of the polyelectrolytes, triggered by ionic strength differentials. We report in vitro characterization of the material properties of GPX, it is in vivo effectiveness in acute animal studies, and its potential for chemoembolization. The viscosity of GPX can be varied over a wide range by adjusting the polyguanidinium MW and/or concentration. Formulation of GPX with either tantalum microparticles (30 wt%) or iodinated radiocontrast agents (300 mgI ml(−1)) did not significantly change the flow behavior of GPX; the viscosity was independent of shear rate and remained within a clinically practical range (80–160 cP). Formulation of GPX with doxorubicin substantially increased viscosity at low shear rates and resulted in a power law dependence on shear rate. High contrast and effective vascular occlusion were demonstrated in both swine kidneys and rete mirabile. Contrast from iodinated compounds was temporary, dissipating within hours. The doxorubicin in vitro release profile was linear over 90 days. The results demonstrate that GPX is a versatile liquid embolic platform that can be formulated with a wide range of viscosities injectable at clinically practical flow rates, with either transient or permanent contrast, and that can provide prolonged zero-order delivery of doxorubicin to embolized tissues. Frontiers Media S.A. 2023-01-16 /pmc/articles/PMC9885798/ /pubmed/36726745 http://dx.doi.org/10.3389/fbioe.2023.1095148 Text en Copyright © 2023 Stewart, Sima, Karz and Jones. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Stewart, Russell J.
Sima, Monika
Karz, Jessica
Jones, Joshua P.
Material characterization of GPX(®): A versatile in situ solidifying embolic platform technology
title Material characterization of GPX(®): A versatile in situ solidifying embolic platform technology
title_full Material characterization of GPX(®): A versatile in situ solidifying embolic platform technology
title_fullStr Material characterization of GPX(®): A versatile in situ solidifying embolic platform technology
title_full_unstemmed Material characterization of GPX(®): A versatile in situ solidifying embolic platform technology
title_short Material characterization of GPX(®): A versatile in situ solidifying embolic platform technology
title_sort material characterization of gpx(®): a versatile in situ solidifying embolic platform technology
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885798/
https://www.ncbi.nlm.nih.gov/pubmed/36726745
http://dx.doi.org/10.3389/fbioe.2023.1095148
work_keys_str_mv AT stewartrussellj materialcharacterizationofgpxaversatileinsitusolidifyingembolicplatformtechnology
AT simamonika materialcharacterizationofgpxaversatileinsitusolidifyingembolicplatformtechnology
AT karzjessica materialcharacterizationofgpxaversatileinsitusolidifyingembolicplatformtechnology
AT jonesjoshuap materialcharacterizationofgpxaversatileinsitusolidifyingembolicplatformtechnology